Table 1.

Baseline characteristics of matched statin users and statin non-user in all ECC cases and all controls

Variable	All ECC			All controls
	Statin user (N=73)	Statin non-user (N=321)	p-value	Statin user (N=403)	Statin non-user (N=385)	p-value
Age in years, mean (SD)	69.3 (10.9)	64.9 (14.3)	0.014	65.9 (12.4)	65.2 (15.0)	0.98
Sex, male	57 (78.1%)	211 (65.7%)	0.041	297 (73.7%)	241 (62.6%)	<0.001
Race			0.082			0.015
White, n (%)	73 (100.0%)	307 (95.6%)		395 (98.0%)	365 (94.8%)
Non-white, n (%)	0 (0.0%)	14 (4.4%)		8 (2.0%)	20 (5.2%)
BMI; mean (SD)	29.1 (5.4)	27.5 (6.1)	0.005	29.5 (4.9)	28.1 (5.5)	<0.001
DM, n (%)	39 (53.4%)	84 (26.2%)	<0.001	209 (51.9%)	94 (24.4%)	<0.001
IBD, n (%)	2 (2.7%)	39 (12.1%)	0.017	7 (1.7%)	4 (1.0%)	0.40
Cirrhosis, n (%)	8 (11.0%)	67 (20.9%)	0.068	34 (8.4%)	25 (6.5%)	0.30
Cholangitis, n (%)	27 (37%)	86 (26.8%)	0.087	1 (0.2%)	0 (0.0%)	0.33
PSC, n (%)	11 (15.1%)	114 (35.5%)	0.005	0 (0.0%)	0 (0.0%)	1.00
HCV, n (%)	2 (2.7%)	19 (5.9%)	0.39	5 (1.2%)	1 (0.3%)	0.11
Other liver disease, n (%)	3 (4.1%)	36 (11.2%)	0.081	11 (2.7%)	10 (2.6%)	0.91
CAD, n (%)	44 (60.3%)	69 (21.5%)	<0.001	209 (51.9%)	49 (12.7%)	<0.001
Stroke, n (%)	6 (8.2%)	1 (0.3%)	<0.001	105 (26.1%)	27 (7.0%)	<0.001
Smoking, n (%)	16 (5.71%)	58 (20.7%)	0.07	199 (25.4%)	175 (22.3%)	0.27
Alcohol use, n (%)	25 (8.93%)	101 (36.1%)	0.04	309 (39.4%)	287 (36.6%)	0.38